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Abstract
Neisseria meningitidis is a human nasopharyngeal commensal capable of causing life-threatening septicemia and meningitis.
Many meningococcal surface structures, including the autotransporter proteins NalP and MspA, are subject to phase
variation (PV) due to the presence of homopolymeric tracts within their coding sequences. The functions of MspA are
unknown. NalP proteolytically cleaves several surface-located virulence factors including the 4CMenB antigen NhbA.
Therefore, NalP is a phase-variable regulator of the meningococcal outer membrane and secretome whose expression may
reduce isolate susceptibility to 4CMenB-induced immune responses. To improve our understanding of the contributions of
MspA and NalP to meningococcal-host interactions, their distribution and phase-variable expression status was studied in
epidemiologically relevant samples, including 127 carriage and 514 invasive isolates representative of multiple clonal
complexes and serogroups. Prevalence estimates of .98% and .88% were obtained for mspA and nalP, respectively, with
no significant differences in their frequencies in disease versus carriage isolates. 16% of serogroup B (MenB) invasive
isolates, predominately from clonal complexes ST-269 and ST-461, lacked nalP. Deletion of nalP often resulted from
recombination events between flanking repetitive elements. PolyC tract lengths ranged from 6–15 bp in nalP and 6–14 bp
in mspA. In an examination of PV status, 58.8% of carriage, and 40.1% of invasive nalP-positive MenB isolates were nalP
phase ON. The frequency of this phenotype was not significantly different in serogroup Y (MenY) carriage strains, but was
significantly higher in invasive MenY strains (86.3%; p,0.0001). Approximately 90% of MenB carriage and invasive isolates
were mspA phase ON; significantly more than MenY carriage (32.7%) or invasive (13.7%) isolates. This differential expression
resulted from different mode mspA tract lengths between the serogroups. Our data indicates a differential requirement for
NalP and MspA expression in MenB and MenY strains and is a step towards understanding the contributions of phase-
variable loci to meningococcal biology.
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Introduction
The encapsulated diplococcus, Neisseria meningitidis, persists in
the upper respiratory tract of 10–30% of individuals without
causing clinical symptoms [1,2]. In rare cases, hyper-virulent
meningococci invade the epithelial layers and enter the blood-
stream resulting in rapidly fatal septicemia and meningitis [1]. The
use of conjugate polysaccharide vaccines targeting some disease-
associated serogroups has helped limit the impact of disease in
several countries; however, a prerequisite for comprehensive
prevention in the developed world will be an effective and widely
used vaccine against serogroup B meningococci (MenB) [3]. One
vaccine developed for this purpose is 4CMenB (Bexsero). This has
been licensed for use in European countries and contains four
antigenic components: factor H binding protein (fHbp), Neisserial
adhesin A (NadA), Neisseria heparin binding antigen (NhbA) and
outer membrane vesicles from a New Zealand epidemic strain [4].
This vaccine is predicted to provide protection against ,78% of
European invasive MenB strains suggesting a requirement for
additional vaccine components [5].
Meningococci elaborate numerous cell-surface and secreted
virulence factors which facilitate colonization of, persistence in,
and damage to, the host [6]. One important class are the
autotransporter (or type V secreted) proteins. Eight have been
identified in meningococci: IgA1 protease, NhhA, AutA, AutB,
NadA, App, NalP (also known as AspA) and MspA (also known as
AusI) [7], five of which were first discovered in our laboratory [8–
11]. Autotransporters share common structural features including a
conserved C-terminal b-barrel translocator domain and a more
variably conserved functional N-terminal passenger domain. The
translocator inserts in the outer membrane and is required for
passenger domain translocation [12,13]. Following export, the
passenger domain of some autotransporters undergoes proteolytic
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cleavage, resulting in the release of biologically active fragments
from their respective cell-bound translocator domain [12]. The
functions of autotransporters vary widely, but often relate to
virulence and include acting as enzymes, adhesins or cytotoxins [14].
The coding sequences of two meningococcal autotransporters,
NalP and MspA, contain poly-cytosine tracts which differ in length
between strains suggesting that their expression is phase variable
[10,11,15,16]. Phase variation (PV) is the reversible switchingONor
OFF of protein expression, often mediated by slipped-strand
mispairing during DNA replication at repeat tracts [17]. PV may
allow bacteria to adapt to changes in their microenvironment [18]
and evade adaptive immune responses [19]. The precise functions of
MspA are unknown, although a role in adhesion of meningococci to
host cells has been suggested [11]. Transcriptome analysis using an
ex vivo model of human whole blood infection revealed significant
increases in mspA expression in blood supporting an important role
for MspA during invasive disease [20].
MspA and NalP both exhibit auto-proteolytic activity resulting
in the release of passenger domain fragments into the external
milieu. The pattern of secreted MspA fragments varies extensively
between strains and is also influenced by the activity of NalP
[11,15]. In addition to targeting itself and MspA, NalP proteolyt-
ically processes other surface proteins including App and IgA1
protease [10,16], LbpB (lactoferrin binding protein B) [21] and the
4CMenB antigen NhbA [22]. The consequences of the proteolytic
activity of NalP on meningococcal pathogenesis are yet to be fully
determined, but a nalP knockout mutant was more sensitive to
killing by human whole blood compared to the wild-type,
suggesting that NalP is a factor (directly or indirectly) involved
in the survival of the meningococcus in this niche [20].
Furthermore, recent work has shown the impact of NalP activity
on DNA-dependent biofilm formation. In meningococci not
expressing NalP, the DNA binding fragments of NhbA and
IgA1 protease are retained on the cell surface resulting in efficient
biofilm formation. In NalP-expressing meningococci, NalP-medi-
ated cleavage and release of these DNA-binding fragments leads to
reduced biofilm formation [23]. NalP expression may also reduce
isolate susceptibility to 4CMenB-induced immune responses since
this vaccine contains the NalP target NhbA; albeit in vitro
bactericidal assays suggest that NhbA processing by NalP does
not significantly affect the susceptibility of isolates to killing by
polyclonal anti-NhbA antibody [22].
In summary, NalP and MspA are outer membrane/secreted
proteins with important roles in meningococcal virulence.
However, understanding the contributions these autotransporters
make to meningococcal-host interactions is hampered by a lack of
detailed studies on their distribution and phase-variable expression
status in epidemiologically relevant samples. In this study, we
determined the presence and expression status of both nalP and
mspA in two recent isolate collections. This analysis showed that
both genes are found at high frequency in both carriage and
invasive isolates, and revealed mechanisms which lead to loss of
nalP in nalP--negative strains. Tract length analysis revealed
differences in the proportions of strains in ON/OFF expression
states between carriage and invasive isolate collections, and
between serogroups, indicating differential requirements for MspA
and NalP expression in different niches and in different
meningococcal lineages.
Materials and Methods
Isolate collections
A subset of 127 isolates, taken from a larger strain collection
obtained from a cohort follow up study of meningococcal carriage
in students at Nottingham University, UK during 2008–09, was
used in this study. Briefly, a cohort of 190 students was sampled for
meningococcal nasopharyngeal carriage at four time-points
throughout the academic year [24]. One representative colony
per individual per time point was sub-cultured for the production
of glycerol stocks and DNA extracts using the DNeasy Blood and
Tissue kit (Qiagen). Strains were confirmed as meningococci using
molecular methods and subsequently PorA, FetA and multilocus
sequence typed and PCR-serogrouped [24]. A total of 214 isolates
were obtained, but for persistently carried meningococcal strains
(i.e. strains with identical fine-typing characteristics carried by the
same individual over multiple time-points), only the first isolate
was included in this study to yield a core set of 127 isolates
comprising all 89 strains obtained at the first time-point and 38
additional strains from other time-points representing acquisition
or clonal replacement events [24]. The Meningitis Research
Foundation Meningococcus Genome Library database (containing
the unfinished genome sequences of all disease isolates for the
epidemiological year 2010–11 in England, Wales and Northern
Ireland) was interrogated by BLAST (last analyzed April 2013) at
http://pubmlst.org/perl/bigsdb/bigsdb.
pl?db= pubmlst_neisseria_mrfgenomes. Additional DNA and
protein sequence analyses were carried out using DNAMAN
v4.13 (Lynnon BioSoft).
PCR amplification and DNA sequence analysis
nalP was detected using primers nalPF1 and nalPR1 (Table 1).
For some strains the resulting amplicons were sequenced using
nalPF1, nalPR1 and nalPR2 (Table 1). nalP deletion and
replacement events were characterized by amplifying using
NMB1968F and NMB1970R (Table 1) and sequencing the
amplified products using the same primers and internal primers.
Detection of mspA was undertaken using mspAF1 and mspAR1
(Table 1); these products were sequenced using these primers and
mspAR2 (Table 1). PolyC tract lengths in nalP and mspA were
determined by a combination of DNA sequencing and sizing of
PCR fragments. For the latter, fragments were amplified using a 6-
carboxyfluorescein (FAM)-labeled primer (nalPF2-FAM or
mspAF2-FAM, respectively) and a non-labeled primer (nalPR2
or mspAR2, respectively) in a 10 ml PCR reaction. PCR products
were A-tailed by the addition of a 4 ml reaction mix containing
0.8 ml PCR buffer (56), 0.4 ml 2mM dATP, 0.04 ml Taq and
2.76 ml distilled H2O, followed by incubation at 72uC for 45 min.
0.5 ml volumes of PCR products (1:100 diluted in H2O) were
mixed with Hi-Di Formamide and GeneScan 500 LIZ size
Table 1. Primers used in this study.
Primer DNA sequence
nalPF1 GTTGCAACAACACTTTCTGCCTGC
nalPR1 GCAGGTTGTCGTTGCTCATCCACG
nalPR2 CAGGCGCTTCCTTCCGCATATACG
NMB1968F CACGGTTTGGAAGAATATCTGC
NMB1970R TGCAAACAACACCGAATGCAGC
mspAF1 TATCGGCAACAACAGGCAACAGGC
mspAR1 TTTTGGGCACGCGTCAGAATGCCG
mspAR2 GGTAGGCACCCAAATCGGCATAGC
nalPF2-FAM AAATGTGCAAAGACAGAAGCATGC
mspAF2-FAM GCAGTCCGCATGGAAGCAGACAGC
doi:10.1371/journal.pone.0069746.t001
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standard (Applied Biosystems), followed by electrophoresis on an
ABI 3130 Genetic Analyzer (Applied Biosystems). GeneScan data
were analyzed using Peak Scanner v1.0 software (Applied
Biosystems) using the local southern size calling method.
Phenotypic analysis
Expression of NalP and MspA in representative strains was
confirmed by immunoblot analysis of concentrated secreted
protein preparations. Secreted proteins were prepared from
200 ml cultures of meningococci grown at 37uC overnight in
Dulbecco’s Modified Eagle Medium (DMEM; Invitrogen). Me-
ningococci were harvested by centrifugation (8,0006g for 10 min)
and supernatants filtered (Steritop 0.22 mm pore size; Millipore)
and concentrated approximately 200-fold (Vivaspin-20 protein
concentrator, 30-kDa molecular weight cut-off; Sartorius). Secret-
ed proteins were electrophoretically separated using 10%
polyacrylamide mini-gels (Mini-Protean III, Bio-Rad) and trans-
ferred to nitrocellulose membranes. Membranes were blocked
with 1% [w/v] bovine serum albumin (BSA), 0.1% [v/v]
TweenH20 in 16 phosphate buffered saline [PBS] overnight at
4uC. Membranes were probed with rabbit anti-MspA [11] or
rabbit anti-NalP [10] diluted 1:4000 or 1:500, respectively in
blocking solution and incubated for 2 h. After washing three times
in 16 PBS with 0.1% TweenH20 (PBST), membranes were
incubated for 2 h with goat anti-rabbit IgG-alkaline phosphatase
conjugate (Sigma), at a dilution of 1:30,000 in blocking solution.
After washing with PBST, the blots were developed using BCIP/
NBT-Blue liquid substrate (Sigma).
Statistical analyses
Statistical analyses were carried out using GraphPad Prism
version 5. P values were derived with a two-tailed Fisher’s exact
test.
Results
Distribution of mspA and nalP in carriage and disease
isolates
We first examined by PCR the distribution of both genes in a
collection of recent UK carriage isolates (n=127) containing
representatives from eight different serogroups (B, C, E, H, W, X,
Y and Z), in addition to non-serogroupable strains [24]. We
observed that 99.2% of carriage isolates harbored mspA, whilst
92.9% had nalP (Table 2). For comparison, in silico examination of
the genome sequences of 514 recent UK invasive isolates revealed
that 97.9% of isolates harbored mspA, whilst 87.7% had nalP
(Table 2). To exclude the possibility that the apparent lack of mspA
or nalP in some genome sequences was due to a lack of coverage,
BLAST analysis was undertaken using the sequences of genes
flanking mspA and nalP (in N. meningitidis MC58, NMB1997 and
NMB1999 for mspA and NMB1968 and NMB1970 for nalP¸
respectively). Highly similar sequences could be detected in all 514
genome sequences, confirming that the 11 (mspA) and 63 (nalP)
invasive isolates identified were negative for the gene of interest
(Tables S1 and S2, respectively). No strains in either collection
lacked both genes and there was no significant difference in the
frequency of mspA or nalP in disease versus carriage isolates
(Table 2). Overall, 98.1% of strains examined possessed mspA
(629/641) and 88.8% (569/641) possessed nalP.
Deletion mechanisms at the nalP locus
Meningococcal isolates lacking mspA have been described
previously [11,15]. In contrast, to our knowledge, this is the first
report describing meningococcal strains lacking nalP. We therefore
investigated nalP deletion mechanisms by amplification of the
deletion loci from the nine nalP-negative carriage isolates using
primers specific for the adjacent genes (NMB1968 encoding
aldehyde dehydrogenase A and NMB1970 encoding a putative
para-aminobenzoate synthase). This analysis revealed that the
PCR products generated from nalP-negative carriage strains
ranged in size from ca. 2-kb to ca. 1.2-kb and could be separated
into four groups (designated DnalP1, DnalP2, DnalP3 and DnalP4)
based on amplicon size (Fig. 1), with the following numbers of
isolates in each group: DnalP1, 1; DnalP2, 3; DnalP3, 2 and DnalP4,
2 (Table 3). No amplicon could be obtained from the remaining
nalP-negative strain perhaps indicating sequence polymorphisms at
the annealing sites of one (or both) of the primers used.
To identify the deletion mechanisms responsible for this
variation in amplicon size, the DNA sequences of the PCR
products shown in Fig. 1 were generated (GenBank accession
numbers KF207543-KF207546) and compared to the nalP locus of
Table 2. Distribution of mspA and nalP in carriage (n= 127) and disease (n= 514) isolates.
Gene Strain collection No. of strains containing gene No. of strains lacking gene P value
mspA carriage 126 (99.2%) 1 (0.8%) 0.4763
invasive 503 (97.9%) 11 (2.1%)
nalP carriage 118 (92.9%) 9 (7.1%) 0.1164
invasive 451 (87.7%) 63 (12.3%)
doi:10.1371/journal.pone.0069746.t002
Figure 1. Variations in the size of the nalP deletion locus
amongst N. meningitidis carriage isolates. The nalP deletion loci
were amplified with primers specific for flanking genes. Amplicons were
grouped into four classes based on size; representative samples are
shown. DnalP1 (V128; Dec), DnalP2 (V130; Nov), DnalP3 (V199; Nov) and
DnalP4 (V206; Dec).
doi:10.1371/journal.pone.0069746.g001
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the MenB strain MC58 [25]. In MC58, nalP is flanked by multiple
repetitive DNA sequences including two clusters of four dRS3
elements (one cluster upstream and one cluster downstream of
nalP). Each dRS3 cluster is flanked by a downstream 26-bp REP4
sequence and upstream and downstream Correia elements (Fig. 2).
Sequencing of nalP deletion loci revealed a variable number of
dRS3 repeats in three of the four deletion types (DnalP2, DnalP3
and DnalP4; Fig. 2) suggesting that deletion of nalP had occurred
via different recombination events between repetitive sequences in
regions upstream and downstream of nalP, leaving residual
fragments of varying lengths between the flanking genes (Fig. 2).
In the case of the DnalP1-class, the sequenced fragment contained
an ORF with 100% identity to the IS1655 transposase gene
indicating that dRS3-independent nalP deletion events also occur.
Further in silico analysis revealed that multiple isolates harboring
DnalP2 and DnalP3 class deletions could be identified within the 63
nalP--negative invasive isolates, thus confirming that similar nalP
deletion types are present in both invasive and carriage isolates
(Table S2).
Distribution of nalP deletion mechanisms within clonal
complexes (CCs)
Strikingly, phylogenetic analyses of strains revealed that the
majority of nalP-negative isolates were restricted to a few CCs,
primarily the ST-461 complex (all 11 strains lacked nalP) and the
ST-269 complex (where 47% of 104 isolates lacked nalP) (Table 4).
Notably, the latter is a hyper-invasive lineage, with a disease/
carriage ratio of 2.8 [2]. Additionally, it was also apparent that the
ST-461 and ST-269 CCs were associated with a different nalP
deletion class, with the former associated with the DnalP2-class,
Table 3. Carriage isolates which lacked nalP.
Volunteer Time pointa Strain typing datab nalP deletion groupc
V128 Dec NG:P1.5,2–12:ND:ST823 (cc198) DnalP1
V64 May NG:P1.17,9:F1-82:ST823 (cc198) ND
V118 Nov E:P1.19,15:ND:ND DnalP2
V130 Nov NG:P.1.7–2,13–2:ND:ST2591 (cc461) DnalP2
V218 Nov E:P1.19,15:F5-28:ND DnalP2
V199 Nov B:P.1.22,9:F5-5:ST283 (cc269) DnalP3
V207 Nov B:P.1.19–1,15-11:F1-7:ST269 (cc269) DnalP3
V192 Dec NG:P1.18–1,3:F3-6:ST3808 (cc254) DnalP4
V206 Dec E:P1.5–1,10–8:F3-6:ST254 (cc254) DnalP4
aTime points indicate when each strain was isolated from a particular carrier. Carriers were sampled in November and December 2008, and February and May 2009.
b, cND, not determined.
doi:10.1371/journal.pone.0069746.t003
Figure 2. Genetic arrangement of the nalP locus in N. meningitidis isolates. Unidirectional arrows represent ORFs. Repetitive elements are
represented by different symbols. dRS3 consensus sequence: ATTCCCNNNNNNNNGGGAAT; REP4 consensus sequence: AAGACCGTCGGGCATCTG-
CAGCCGTC. Other repetitive sequences are not shown for clarity. Note that the figure is not drawn to scale but is a representation of the various
repeat elements and genes present at the nalP locus in N. meningitidis MC58 and four nalP-negative carriage isolates representing DnalP1, DnalP2,
DnalP3 and DnalP4 classes.
doi:10.1371/journal.pone.0069746.g002
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whilst strains from the latter complex commonly harbored DnalP3-
class deletions (Tables 3 and S2). Other CCs also harbored
apparently high proportions of strains lacking nalP, for example
67% and 100% of strains from CCs ST-198 and ST-254,
respectively, lacked nalP, however examination of larger numbers
of strains from these CCs will be required to determine whether
nalP is commonly absent in these lineages.
PV status of mspA and nalP in carriage and invasive
strains
Having shown that most meningococcal isolates contain mspA
and nalP, we examined the ON/OFF status of both autotran-
sporters in the carriage isolates by a combination of sizing of
fluorescent PCR products (i.e. GeneScan) and DNA sequencing.
The expression status of NalP in representative carriage strains
with different tract lengths was confirmed by immunoblot analysis
of secreted protein preparations using specific antisera indicating
that the genetic screen for ON/OFF PV states correlated with the
phenotypic expression of NalP (Fig. 3). Similar analysis confirmed
that a homopolymeric tract length of 6, 9 or 12Cs resulted in
MspA expression (data not shown).
The PV status of mspA and nalP in invasive strains was also
determined by in silico examination of their genome sequences.
Tract lengths could not be defined for a minority of strains in this
collection since in these strains the mspA or nalP polyC tract
spanned multiple contigs. However, from 503 mspA-positive
invasive strains, we were able to determine the mspA tract length
in 500 isolates (99.4%), and for 451 nalP-positive invasive strains,
we determined the nalP tract length in 430 isolates (95.3%).
Tract lengths ranged from 6–14 bp (mode= 9, phase ON) in
mspA (Fig. 4A), and 6–15 bp (mode= 10; phase ON) in nalP
(Fig. 4B). There was no significant difference (p=0.1188) in the
frequency of nalP phase ON (tract length of 7, 10 or 13Cs) strains
in disease versus carriage isolates (Table 5); approximately 50% of
strains in both collections were nalP phase ON. In contrast, a
highly significant difference (p,0.0001) was detected in the
Table 4. Phylogenetic breakdowns of both carriage and invasive strain collections showing the frequency of nalP deletions within
clonal complexes.
Clonal Complex Carriage only Invasive only Carriage & Invasive
Number of
isolates
Number of isolates lacking
nalP
Number of
isolates
Number of isolates
lacking nalP
Number of
isolates
Number of isolates
lacking nalP (%)a
Not assigned 25 2 46 1 71 3 (4)
174 17 0 9 0 26 0
23 15 0 57 0 72 0
1157 12 0 3 0 15 0
60 12 0 15 0 27 0
167 10 0 4 0 14 0
213 6 0 37 0 43 0
22 6 0 13 0 19 0
103 5 0 5 1 10 1 (10)
269 4 2 100 47 104 49 (47)
198 3 2 0 0 3 2 (67)
41/44 3 0 136 3 139 3 (2)
53 3 0 0 0 3 0
254 2 2 0 0 2 2 (100)
32 2 0 29 0 31 0
35 1 0 8 1 9 1 (11)
461 1 1 10 10 11 11 (100)
11 0 0 21 0 21 0
Others 0 0 21 0 21 0
Total 127 9 514 63 641 72
a(%) indicates the percentage of isolates within each clonal complex which were nalP--negative.
doi:10.1371/journal.pone.0069746.t004
Figure 3. Immunoblot confirmation that nalP tract lengths of 7,
10 or 13Cs results in NalP expression. Secreted protein
preparations from representative strains were probed with rabbit
anti-NalP antisera to confirm that only nalP homopolymeric tract
lengths of 7, 10 or 13Cs are consistent with the gene being in-frame
and phase ON. Secreted NalP fragments ranged in size between ca. 68–
70kDa due to sequence polymorphisms between alleles [10,16]. Strains
used (tract length in parentheses): V199; May (7), V1114; Nov (8), V78;
Nov (9), V131; Nov (10), V182; Nov (11), V169; Dec (12) and V193; Nov
(13).
doi:10.1371/journal.pone.0069746.g003
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frequency of mspA phase ON (tract length of 6, 9 or 12Cs) strains
in the carriage versus invasive collections (Table 6), with mspA
being significantly more often ON in invasive isolates compared to
carriage isolates (69.2% compared to 50.0%).
Influence of serogroup on PV status
The invasive strain collection used in this study had the
following composition: 76.3% MenB, 14.4% MenY and 9.3%
from other serogroups. In contrast, the carriage isolate collection
comprised 15% MenB, 40.9% MenY and 44.1% from other
serogroups. To understand whether these differences were
influencing our observations regarding shifts in ON/OFF status
between carriage and invasive collections, we examined tract
lengths in both isolate collections by serogroup, with particular
focus on MenB and MenY strains.
For nalP harbored by MenY strains, there was a significant
difference between the frequency of the phase ON phenotype
during carriage and invasive disease (69.2% ON in carriage to
86.3% ON in invasive; p = 0.0259). However, no corresponding
statistically significant changes were apparent for MenB strains
and the remaining non-B, non-Y strain group (Table 5 and
Fig. S1) leading to no overall significant change in the proportions
of strains in ON or OFF PV states in carriage versus invasive
collections. In each serogroup and under each condition (carriage
or invasive), the mode tract length in nalP was 10Cs (phase ON).
Notably, the frequency of the ON phenotype was significantly
higher in invasive MenY strains than invasive MenB strains
(86.3% versus 40.1%; p,0.0001), whilst the frequency of the ON
phenotype was not statistically different (p = 0.5547) between
carried MenY and MenB strains.
For mspA, serogroup-specific differences were more evident
(Table 6 and Fig. S2). For MenB strains, 89.5% of carriage, and
86.1% of invasive isolates, respectively, were mspA phase ON. In
contrast, only 32.7% of carriage and 13.7% of invasive MenY
strains were mspA phase ON, with the shift to an mspA OFF
phenotype in MenY invasive strains being statistically significant
(p = 0.015). For both carriage and invasive isolates, the frequency
of the mspA phase ON phenotype was significantly higher in MenB
strains than MenY strains (p,0.0001 for both comparisons). The
basis for this difference was apparent from our tract length analysis
which showed that the mode tract length for MenB strains was
9Cs (phase ON), whilst for MenY strains the mode was 7Cs (phase
OFF) (Fig. S2). The breakdown by serogroup also clarified the
apparent overall switch to mspA being phase ON during invasive
disease. This was likely to be a consequence of the overrepresen-
tation of MenB strains (with mspA ON in 86.1% of them) in the
invasive collection (n = 328 MenB phase ON strains from 500
invasive strains examined; 65.6%) compared to their frequency in
the carriage collection (n = 17 MenB phase ON strains from 126
carriage strains examined; 13.5%). Taken together, this data
identifies correlations between serogroup and specific tract lengths,
and hence differential expression states, of MspA in MenB and
MenY meningococci.
Prevalence of a premature TAG stop codon in mspA
Previous studies on mspA have noted that in some strains from
ST-11, the gene contains a single nucleotide mutation (C to T)
which places a premature TAG stop codon in frame [11,15]. Thus
in these strains the gene is interrupted even if the number of Cs in
the mspA polyC tract would lead to an in-frame ORF. Our
Figure 4. Distribution of tract lengths for mspA (A) and nalP (B)
in invasive and carriage isolates. Invasive isolates shown are a sub-
set of the 2010–11 UK isolates available in the Meningitis Research
Foundation Meningococcus Genome Library database. Carriage isolates
were from a study of meningococcal carriage in students at Nottingham
University, UK during 2008–09. Black bars, carriage; grey bars, invasive.
An ON PV state is produced by 6, 9 or 12Cs for mspA and by 7, 10 or
13Cs for nalP.
doi:10.1371/journal.pone.0069746.g004
Table 5. Distribution of phase ON and OFF nalP genes in carriage and disease isolates by serogroup.
Serogroup Carriage Invasive P value
No. of strains phase ON No. of strains phase OFF No. of strains phase ON No. of strains phase OFF
B 10 (58.8%)a 7 (41.2%) 125 (40.1%)b 187 (59.9%) 0.1366
Y 36 (69.2%)a 16 (30.8%) 63 (86.3%)b 10 (13.7%) 0.0259
Others 22 (44.9%) 27 (55.1%) 23 (51.1%) 22 (48.9%) 0.6797
Total 68 (57.6%) 50 (42.4%) 211 (49.1%) 219 (50.9%) 0.1188
aNo statistically significant difference in the frequency of the nalP phase ON phenotype between MenB and MenY carriage isolates (p= 0.5547).
bStatistically significant difference in the frequency of the nalP phase ON phenotype between MenB and MenY invasive isolates (p,0.0001).
doi:10.1371/journal.pone.0069746.t005
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collection of carriage strains contained no strains from this lineage;
however 21 invasive isolates belonged to ST-11 (Table 4). In silico
analysis showed that 15 of these harbored the C to T mutation,
but all contained polyC tracts containing a number of nucleotides
consistent with the gene being phase OFF. This analysis also
confirmed that this mutation was limited to ST-11 strains, since no
other strains were identified that harbored this C to T substitution.
Discussion
NalP and MspA are meningococcal autotransporter proteases,
but their precise biological significance remains unclear [7]. In
addition to functional studies, investigating the distribution and
PV-mediated expression of mspA and nalP in disease and carriage
isolates may lead to an improved understanding of the role of these
proteins in pathogenesis and disease progression. Previous studies
have looked at the prevalence of mspA and nalP in small numbers
of isolates (typically ,20 strains) [10,11,15,16]. In this study, we
investigated the prevalence of both genes in a considerably larger
(n=641) collection of epidemiologically relevant strains. Overall,
98.1% of strains examined possessed mspA and 88.8% possessed
nalP with no significant differences between the frequencies of
either gene in carriage versus invasive isolates. This is in contrast
to the phase variably expressed gene, hmbR, (encoding for the
HmbR haemoglobin receptor) which has been detected at a
significantly higher frequency in disease compared to carriage
isolates [26,27].
The identification of nalP-negative strains was especially
significant since, to our knowledge, strains lacking nalP have not
been noted previously. Characterization of the deletion loci in
carriage isolates identified four types of deletion event involving
either recombination events between highly similar flanking
sequences or replacement with IS1655. Similar events have
previously been associated with the deletion of meningococcal
genes encoding other surface localized proteins including FetA,
PorA and HpuAB [27–30]. Multiple strains from the invasive
collection could also be assigned by BLAST to one of the deletion
classes. Unfortunately, the remaining nalP deletion loci spanned
multiple contigs, and their complex and repeat-rich nature
precluded in silico reassembly. Completion of the genome
sequences in the MRF library database will allow further strains
to be assigned to each of four deletion classes and may allow for
the identification of additional mechanisms of nalP deletion.
The nalP gene was absent in 72 of the strains examined, 83%
(60/72) of these deletion events were associated with two lineages,
ST-461 and ST-269. The latter is a diverse lineage composed of
over 30 distinct STs, which can be split into two distinct groups,
the ST-269 and ST-275 clusters, respectively [31]. All the ST-269
nalP-negative strains were from STs found in the ST-269 cluster
(data not shown). Interestingly, the ST-461 and ST-269 lineages
were each associated with a specific type of nalP deletion event.
Stable lineages of this type suggest that nalP deletion is infrequent,
possibly because the selective advantage associated with deletion of
the gene is low. However, it should be noted that other CCs, for
example, the ST-41/44 complex, contained strains lacking nalP at
low frequencies suggesting that sporadic nalP deletion events can
also occur.
Having shown that most meningococcal isolates contain mspA
and nalP, we examined the polyC tract lengths of both
autotransporters in both isolate collections. PolyC tract lengths
in mspA ranging from 6 to 10 bp long have been described [15].
Our data extends this to show that tract lengths up to 14 bp long
can be harbored by meningococci. Similarly, tract lengths in nalP
ranging in size between 9–15 bp have previously been noted [10];
our analysis extends this to show that smaller tract lengths (down
to 6 bp) can also be found.
Importantly, our tract length analysis revealed some important
differences regarding PV-mediated expression of the two auto-
transporters between serogroups and in different niches. For
MenB strains, the frequency of NalP expression was not
significantly different between carriage or invasive strain collec-
tions, with expression (phase ON) predicted in 58.8% and 40.1%
of carriage and invasive strains, respectively. However, the former
estimate was based on only 17 strains; analysis of a larger number
of carried MenB isolates may lead to a refinement in this estimate.
Intriguingly, our estimates for NalP expression were considerably
higher in MenY strains, indicating a greater requirement for NalP
expression in MenY lineages, particularly during invasive disease.
It has previously been shown that a MenB nalP knockout mutant
was more sensitive to killing by human whole blood compared to
the wild-type. This suggests that NalP is a factor involved in blood
survival (in MenB at least) [20]. The importance of this protective
role in blood is undermined by our finding that 16% (61/392) of
the MenB disease isolates from England, Wales and Northern
Ireland in 2010–11 lacked nalP and furthermore, that ca. 60% of
nalP-positive invasive MenB strains were not expressing the
protein. This would suggest that either NalP is not essential to
the development of invasive disease or that another protein may
compensate for the loss of NalP in MenB. It is feasible that in other
serogroups (such as MenY), the greater frequency of NalP
expression during invasive disease is due to the absence of this
compensating protein, however this requires further experimental
confirmation.
One target for NalP-mediated cleavage is NhbA [22]. A
recombinant derivative of this 60-kDa lipoprotein is one of four
antigenic components in the newly licensed anti-MenB vaccine,
Table 6. Distribution of phase ON and OFF mspA genes in carriage and disease isolates by serogroup.
Serogroup Carriage Invasive P value
No. of strains phase ON No. of strains phase OFF No. of strains phase ON No. of strains phase OFF
B 17 (89.5%)a 2 (10.5%) 328 (86.1%)b 53 (13.9%) 1.0000
Y 17 (32.7% )a 35 (67.3%) 10 (13.7%)b 63 (86.3%) 0.0150
Others 29 (52.7%) 26 (47.3%) 8 (17.4%) 38 (82.6%)c 0.0004
Total 63 (50.0%) 63 (50.0%) 346 (69.2%) 154 (30.8%) ,0.0001
aStatistically significant difference in the frequency of the mspA phase ON phenotype between MenB and MenY carriage isolates (p,0.0001).
bStatistically significant difference in the frequency of the mspA phase ON phenotype between MenB and MenY invasive isolates (p,0.0001).
cIncludes 15 strains from ST-11 which harbor a mutation in mspA interrupting the gene. All 15 strains were phase OFF at the polyC tract.
doi:10.1371/journal.pone.0069746.t006
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4CMenB (Bexsero) [32]. Outer membrane-localized NhbA can be
incompletely cleaved by NalP to release a 22-kDa fragment,
corresponding to the C-terminal region of NhbA, into the external
milieu [22]. This has led to concerns that NalP expression may
reduce the susceptibility of MenB isolates to 4CMenB-induced
immune responses. Our findings suggest that this will not be a
universal effect as nalP is absent in some MenB lineages, whilst a
high proportion (59%; 194/329) of nalP-positive MenB strains
examined were not expressing this protein.
NalP proteolytic activity has also been shown to influence DNA-
dependent biofilm formation, with maximal biofilm formation
seen in meningococcal strains not expressing NalP [23]. The phase
variable expression of NalP has therefore been suggested to
influence meningococcal dispersal and the colonization of new
niches and carriers [23]. Although biofilm formation is likely to a
complex and multi-factorial process, our data would suggest that
since MenB strains are generally less likely to be expressing NalP,
they would be more likely to efficiently form biofilms than MenY
strains. The influence of NalP on biofilm formation in MenY
strains and any resulting effects on their transmissibility and
propensity to cause disease compared to MenB strains remain
unclear.
For mspA, niche-specific and serogroup-specific differences in
PV-expression were also apparent. Approximately 90% of mspA-
positive carriage and invasive MenB strains were expressing
MspA. This complements previously reported data which showed
that mspA expression in MenB significantly increases in blood [20]
and suggests an important role for MspA during the development
of MenB invasive disease (and also potentially during carriage). In
contrast, estimates of MspA expression in mspA-positive MenY
strains were significantly lower, with only 32.7% of carriage strains
expressing MspA, dropping significantly to 13.7% for invasive
isolates. Like NalP, this indicates a differential requirement for
MspA expression in MenB and MenY strains. MspA-expressing E.
coli showed significantly increased adherence in vitro to human cells
compared to non-expressing cells [11], however in a separate
study, the adhesion of N. meningitidis to various human epithelial
and monocyte cell lines was unaffected by mspA mutation in a
MenB strain [15]. Furthermore, inactivation of mspA did not
influence other phenotypes including host cell invasion, utilization
of hemoglobin and hemin as iron sources, hemagglutination nor
serum resistance [15]. Thus, further studies are required to
determine the function of MspA, and to explain the consequences
of differential rates of MspA expression amongst serogroups. This
differential expression may be important in meningococcal disease
as MenY strains are associated with a predilection for infecting
older age groups and causing pneumonia, whilst MenB disease
(septicemia and meningitis) is more prevalent in infants and
toddlers [33]. Finally, our data also shows that although mspA is
highly prevalent in invasive strains, the development of clinical
disease is not dependent per se on MspA expression since strains
lacking the gene or harboring mutations that would prevent MspA
expression (irrespective of phase ON/OFF status) can be found in
collections of invasive strains. As with nalP, this may indicate
redundancy and the presence of another protein which could
replace the functionality of MspA in these strains.
In summary, two phase-variably expressed meningococcal
autotransporters, NalP and MspA, are highly prevalent in both
carriage and disease isolates. In some cases, differences in the
proportions of strains in ON/OFF expression states were apparent
between carriage and invasive isolate collections, and between
serogroups, indicating differential requirements for MspA and
NalP expression in different niches and in different meningococcal
lineages. This analysis is a step towards understanding the
potential contributions of phase variable loci to meningococcal
carriage and disease, and also shows the utility of having a freely-
available source of large numbers of bacterial genomes represen-
tative of a particular source or phenotype.
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